Antisense Therapeutics (ASX:ANP)
Mark Diamond
CEO
Market Cap (AUD): 25.42M
Sector: Health Care
Last Trade (AUD):
0.052 +0.01 (+23.81%)
Tab Bar
1. About
Antisense Therapeutics Limited (ASX:ANP) is a biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.